|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US6267964B1
(en)
|
1989-08-01 |
2001-07-31 |
Affibody Technology Sweden Ab |
Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
GB8918616D0
(en)
|
1989-08-15 |
1989-09-27 |
Univ Glasgow |
Herpes simplex virus type 1 mutant
|
|
US20020164782A1
(en)
|
1999-02-10 |
2002-11-07 |
Gregory Richard J. |
Adenovirus vectors for gene therapy
|
|
JPH04292169A
(ja)
|
1991-03-19 |
1992-10-16 |
Sekisui Chem Co Ltd |
ハイブリッド型人工膵臓
|
|
US5418618A
(en)
|
1992-03-09 |
1995-05-23 |
Mita Industrial Co., Ltd. |
Tone processing method for forming a halftone image
|
|
US5804413A
(en)
|
1992-07-31 |
1998-09-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
US5808656A
(en)
|
1993-09-15 |
1998-09-15 |
Oce Printing Systems Gmbh |
Arrangement and process for generating a matrix image on a photosensitive recording substrate
|
|
WO1995019570A1
(en)
|
1994-01-14 |
1995-07-20 |
Genentech, Inc. |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
|
GB9415319D0
(en)
|
1994-07-29 |
1994-09-21 |
Medical Res Council |
HSV viral vector
|
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US6825396B2
(en)
|
1996-06-12 |
2004-11-30 |
Board Of Trustees Operating Michigan State University |
Methods for tissue specific synthesis of protein in eggs of transgenic hens
|
|
US6455495B1
(en)
|
1997-02-14 |
2002-09-24 |
The Salk Institute For Biological Studies |
Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
AU8605598A
(en)
|
1997-07-31 |
1999-02-22 |
University Of Pittsburgh |
Targeted hsv vectors
|
|
JP2001520009A
(ja)
|
1997-10-16 |
2001-10-30 |
ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド |
鳥の導入遺伝子についてのマグナム特異的プロモーターを含むベクター
|
|
US20040019923A1
(en)
|
1997-10-16 |
2004-01-29 |
Ivarie Robert D. |
Exogenous proteins expressed in avians and their eggs
|
|
US5932465A
(en)
|
1997-10-16 |
1999-08-03 |
Icos Corporation |
Phosphodiesterase 8A
|
|
EP1032662B1
(en)
|
1997-11-07 |
2006-03-08 |
Trillium Therapeutics Inc. |
Methods and compositions for immunomodulation
|
|
US6894022B1
(en)
|
1998-08-27 |
2005-05-17 |
Eidgenossische Technische Hochschule Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
US6272859B1
(en)
|
1998-10-02 |
2001-08-14 |
Caterpillar Inc. |
Device for controlling a variable geometry turbocharger
|
|
US6043056A
(en)
|
1998-11-06 |
2000-03-28 |
Incyte Pharmaceuticals, Inc. |
Cell surface glycoproteins
|
|
CA2353550A1
(en)
|
1998-12-03 |
2000-06-08 |
Histatek, Llc |
Small peptides and methods for treatment of asthma and inflammation
|
|
CA2379166C
(en)
|
1999-08-09 |
2013-03-26 |
Targeted Genetics Corporation |
Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs
|
|
JP3983449B2
(ja)
|
1999-10-15 |
2007-09-26 |
株式会社リコー |
パルス幅変調回路、光書き込み装置及び画像形成装置
|
|
EP1240337B1
(en)
|
1999-12-24 |
2006-08-23 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
EP1259649B1
(en)
|
2000-02-23 |
2009-11-04 |
Pxe international Inc. |
Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions
|
|
JP2001274989A
(ja)
|
2000-03-27 |
2001-10-05 |
Ricoh Co Ltd |
画像処理装置及び画像処理方法並びにプリンタ出力装置
|
|
DE20121960U1
(de)
|
2000-04-06 |
2004-01-15 |
Epigenomics Ag |
Nukleinsäuren für die Diagnose von mit Metastase assoziierten Krankheiten
|
|
WO2002012182A1
(fr)
|
2000-08-08 |
2002-02-14 |
Chugai Seiyaku Kabushiki Kaisha |
Derives de 3-methyl-20-epi-vitamine d
|
|
US6521645B2
(en)
|
2000-11-20 |
2003-02-18 |
The University Of Kansas Medical Center |
Methods for the treatment and prevention of urinary stone disease
|
|
US7083784B2
(en)
|
2000-12-12 |
2006-08-01 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
|
US20020108132A1
(en)
|
2001-02-02 |
2002-08-08 |
Avigenics Inc. |
Production of a monoclonal antibody by a transgenic chicken
|
|
AU2002335930B2
(en)
|
2001-03-09 |
2005-07-28 |
Morphosys Ag |
Serum albumin binding moieties
|
|
US20020183276A1
(en)
|
2001-03-23 |
2002-12-05 |
Burnham Institute |
Compositions and methods for modulating bone mineral deposition
|
|
US7888372B2
(en)
|
2001-03-23 |
2011-02-15 |
National Institutes Of Health (Nih) |
Compositions and methods for modulating bone mineral deposition
|
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
|
AU2002324700A1
(en)
|
2001-08-14 |
2003-03-03 |
Bayer Ag |
Nucleic acid and amino acid sequences involved in pain
|
|
WO2003025146A2
(en)
|
2001-09-18 |
2003-03-27 |
Avigenics, Inc. |
Production of a transgenic avian by cytoplasmic injection
|
|
JP4200100B2
(ja)
|
2001-11-07 |
2008-12-24 |
アジェンシス，インコーポレイテッド |
癌の処置および検出において有用な１６１ｐ２ｆ１０ｂと称される、核酸および対応タンパク質
|
|
US7294507B2
(en)
|
2001-11-30 |
2007-11-13 |
Avigenics, Inc. |
Ovomucoid promoters and methods of use
|
|
US6875588B2
(en)
|
2001-11-30 |
2005-04-05 |
Avigenics, Inc. |
Ovomucoid promoter and methods of use
|
|
US7335761B2
(en)
|
2001-11-30 |
2008-02-26 |
Avigenics, Inc. |
Avian gene expression controlling regions
|
|
US7858297B2
(en)
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
|
WO2003072593A2
(en)
|
2002-02-21 |
2003-09-04 |
University Of Virginia Patent Foundation |
Bone targeting peptides
|
|
AU2003210806A1
(en)
|
2002-03-05 |
2003-09-22 |
Eli Lilly And Company |
Heterologous g-csf fusion proteins
|
|
EP1576172A2
(en)
|
2002-06-21 |
2005-09-21 |
Dyax Corporation |
Serum protein-associated target-specific ligands and identification method therefor
|
|
US20040224893A1
(en)
|
2003-05-06 |
2004-11-11 |
Li-Hsien Wang |
Methods of using IL-1 antagonists to treat neointimal hyperplasia
|
|
US20050090001A1
(en)
|
2003-10-07 |
2005-04-28 |
Parker Stephen H. |
Cell lines and methods for producing proteins
|
|
HUE027902T2
(en)
|
2004-02-09 |
2016-11-28 |
Human Genome Sciences Inc Corp Service Company |
Albumin fusion proteins
|
|
CA2559228C
(en)
|
2004-04-21 |
2016-06-21 |
Enobia Pharma Inc. |
Bone delivery conjugates and method of using same to target proteins to bone
|
|
US9055984B2
(en)
|
2004-04-21 |
2015-06-16 |
DePuy Synthes Products, Inc. |
Sternal reconstruction system
|
|
US20050287284A1
(en)
|
2004-06-28 |
2005-12-29 |
Shukla Triveni P |
Processed meats comprising dietary fiber gel
|
|
US20090142347A1
(en)
|
2004-09-29 |
2009-06-04 |
The Burnham Institute For Medical Research |
Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification
|
|
AU2005302408B2
(en)
|
2004-10-28 |
2012-08-09 |
The Government of the United States of America as represented by the Department of Veterans Affairs |
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
|
|
US8110660B2
(en)
|
2004-11-19 |
2012-02-07 |
Ono Pharmaceutical Co., Ltd. |
Soluble ENPP4 protein
|
|
GB0426397D0
(en)
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
|
JP4495210B2
(ja)
|
2005-06-09 |
2010-06-30 |
パナソニック株式会社 |
振幅誤差補償装置及び直交度誤差補償装置
|
|
JP5199077B2
(ja)
|
2005-06-10 |
2013-05-15 |
アルタス ファーマシューティカルズ インコーポレイテッド |
シュウ酸オキシダーゼ結晶の投与による、シュウ酸塩濃度を低下させるための方法
|
|
EP1736553A1
(en)
|
2005-06-17 |
2006-12-27 |
Centre National De La Recherche Scientifique |
ENPP1 (PC-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications
|
|
US20090180989A1
(en)
|
2005-10-05 |
2009-07-16 |
Synageva Biopharma Corp. |
Compositions and methods for delivering nucleotide sequences to vertebrates
|
|
US11039942B2
(en)
|
2006-06-13 |
2021-06-22 |
Sino Medical Sciences Technology Inc. |
Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers
|
|
WO2008105911A2
(en)
|
2006-08-02 |
2008-09-04 |
Altus Pharmaceuticals Inc. |
Crystallized oxalate decarboxylase and methods of use
|
|
AU2007293614A1
(en)
|
2006-09-08 |
2008-03-13 |
Ablynx N.V. |
Serum albumin binding proteins with long half-lives
|
|
HRP20100638T2
(hr)
|
2006-11-28 |
2011-03-31 |
Proyecto De Biomedicina Cima |
Viralni vektori i njihova uporaba
|
|
US20080273206A1
(en)
|
2007-04-23 |
2008-11-06 |
University Of South Carolina |
Biomimetic Mineralization Method and System
|
|
HUE031655T2
(hu)
|
2007-05-11 |
2017-07-28 |
Alexion Pharma Inc |
Csontot targetáló alkálikus foszfatáz, készletek és eljárások alkalmazásukra
|
|
ATE520414T1
(de)
|
2007-06-18 |
2011-09-15 |
Univ Oregon Health & Science |
Protein c zur verwendung bei der aufrechterhaltung der hämostase
|
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
GB0803352D0
(en)
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
|
PE20100141A1
(es)
|
2008-05-23 |
2010-02-22 |
Wyeth Corp |
Proteina de union al receptor de interleuquina 21
|
|
JP4888439B2
(ja)
|
2008-05-30 |
2012-02-29 |
ブラザー工業株式会社 |
画像読取装置および原稿サイズ決定プログラム
|
|
US9169492B2
(en)
|
2010-02-05 |
2015-10-27 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
|
US8846603B2
(en)
|
2010-03-12 |
2014-09-30 |
Synageva Biopharma Corp. |
NPP1 fusion proteins
|
|
RU2601154C2
(ru)
|
2011-03-11 |
2016-10-27 |
Синаджива Байофарма Корп |
Гибридные белки npp1
|
|
EA201301082A1
(ru)
|
2011-03-29 |
2014-01-30 |
Бета-Селл Нв |
Способ изготовления инкапсулированных терапевтических продуктов и их применение
|
|
US9642896B1
(en)
|
2011-11-14 |
2017-05-09 |
Yale University |
Compositions and methods for modulating coagulation
|
|
KR20150103269A
(ko)
|
2013-01-04 |
2015-09-09 |
렘펙스 파머수티클스 인코퍼레이티드 |
보론산 유도체 및 그의 치료적 용도
|
|
WO2014126965A2
(en)
|
2013-02-13 |
2014-08-21 |
Yale University |
Compositions and methods for treating pathological calcification and ossification
|
|
EP2970940B1
(en)
|
2013-03-14 |
2018-07-25 |
Translate Bio, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
ES2708565T3
(es)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
|
ES2523016B1
(es)
|
2013-05-20 |
2015-09-09 |
3P Biopharmaceuticals |
Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes
|
|
AU2014305843B2
(en)
|
2013-08-09 |
2019-08-29 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
BR112016006071B1
(pt)
|
2013-09-19 |
2021-12-28 |
Universitãtsspital Basel |
Enxerto vascular artificial e método para a produção de um enxerto vascular artificial
|
|
DK3107562T3
(da)
|
2014-02-19 |
2019-12-16 |
Bioasis Technologies Inc |
P97-ids-fusionsproteiner
|
|
GB2526339A
(en)
|
2014-05-21 |
2015-11-25 |
Imp Innovations Ltd |
Lentiviral vectors
|
|
EP3194430A1
(en)
|
2014-09-16 |
2017-07-26 |
Universitat Autònoma De Barcelona |
Adeno-associated viral vectors for the gene therapy of metabolic diseases
|
|
EP3967755B1
(en)
|
2014-12-19 |
2024-03-27 |
Inozyme Pharma, Inc. |
Soluble npp1 for use in a method for treating pseudoxanthoma elasticum
|
|
US10926006B2
(en)
|
2015-02-26 |
2021-02-23 |
Remodeless Cv Ltd |
Drug eluting stent
|
|
EP4414028A3
(en)
|
2015-05-19 |
2024-11-27 |
Yale University |
Compositions for treating pathological calcification conditions, and methods using same
|
|
ES3034857T3
(en)
|
2015-11-12 |
2025-08-25 |
The Res Institute At Nationwide Childrens Hospital |
Methods of treating muscular dystrophy
|
|
EP3377105A4
(en)
*
|
2015-11-20 |
2019-04-24 |
Yale University |
COMPOSITIONS FOR THE TREATMENT OF ECTOPIC CALIBRATION DISORDERS AND METHODS THEREWITH
|
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
EP3471747A1
(en)
*
|
2016-06-16 |
2019-04-24 |
Alexion Pharmaceuticals, Inc. |
Methods of treating myointimal proliferation
|
|
CA3032467A1
(en)
|
2016-08-05 |
2018-02-08 |
Yale University |
Compositions and methods for stroke prevention in pediatric sickle cell anemia patients
|
|
US20190367579A1
(en)
|
2017-02-27 |
2019-12-05 |
Shattuck Labs, Inc. |
Tigit- and light-based chimeric proteins
|
|
US12134790B2
(en)
|
2017-09-27 |
2024-11-05 |
Inozyme Pharma, Inc. |
Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)
|
|
AU2019267545A1
(en)
|
2018-05-08 |
2020-11-26 |
Yale University |
Compositions and methods for reducing progression of nephrolithiasis
|